PCN176 - A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERSUS DOCETAXEL FOR PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN BELGIUM
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.259
https://www.valueinhealthjournal.com/article/S1098-3015(18)33559-9/fulltext
Title :
PCN176 - A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERSUS DOCETAXEL FOR PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN BELGIUM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33559-9&doi=10.1016/j.jval.2018.09.259
First page :
Section Title :
Open access? :
No
Section Order :
1951